Social Capital Hedosophia Holdings Corp. III
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $828.00M |
|---|---|
| IPO Date | Apr 22, 2020 |
| CEO | Chamath Palihapitiya |
| Left Lead | Credit Suisse |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Technology
Technology outside the US |
| IPO Geography | Global |
| Target Company | Clover Health |
| Deal Announced | Oct 6, 2020 |
| Deal Size, $M | $3,702.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Jan 6, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jan 7, 2021 |
Formerly IPOC
CLOV
CLOVW
| Price | $3.33 |
|---|---|
| Last closing price | $3.28 |
| H/L, today | $3.23 / $3.36 |
| H/L, 52-week | $0.71 / $1.63 |
| Volume, today | 4,558,087 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Social Capital Hedosophia Holdings Corp. III:
- Structure and cap table
- 6 directors & officers
- 27 filings and events
- 1 underwriters
- 7 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Chamath Palihapitiya | 43 | Chief Executive Officer and Chairman of the board of directors |
| Ian Osborne | 36 | President and Director |
| Steven Trieu | 41 | Chief Financial Officer |
| Simon Williams | 39 | General Counsel and Secretary |
| Dr. James Ryans | 43 | Director |
| Jacqueline D. Reses | 50 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Credit Suisse | BR | 72,000,000 | units |
| 72,000,000 | units | ||
| Up-Front UW fee | 1.74 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.